NSE-listed companies investing in specialty chemicals manufacturing — from fluorochemicals and agrochemical intermediates to pharma CDMO and chlorine derivatives — as India targets a $255 billion chemicals industry by 2030.
Sectors represented: Chemicals
Laxmi’s specialty business, offering an opportunity to. leverage best in class technonology and established. customer relationships. category. of refrigerants and surfactants. This business complements. Laxmi’s specialty business, offering an opportunity to. leverage best in class technonology and established. customer relationships. As revenues from the commissioned.
The unit adds around 60,000 MT of capacity, scaling our. annual Acetic Anhydride capacity to 210,000 MT. Our. enhanced capacity will help us to increase our global. presence and achieve a leadership position in global. merchant markets. ydride capacity to 210,000 MT. Our. enhanced capacity will help us to increase our global. presence and achieve a leadership position in global. merchant markets.
We prioritise farmers' needs by. ensuring they have access to. the right products. Our strong. relationships with distribution. channels enable us to understand. specific challenges faced by. farmers. alue. We prioritise farmers' needs by. ensuring they have access to. the right products. Our strong. relationships with distribution. channels enable us to understand. specific challenges faced by.
Agro & Specialty Chemical facility. at Dahej III (Gujarat). 50,000 sq meters greenfield plant in. GIDC, Dahej, Gujarat. Commenced operations from Sept. 2024 y – Onco &. Non-Onco at Dahej I/II (Gujarat). Agro & Specialty Chemical facility. at Dahej III (Gujarat). 50,000 sq meters greenfield plant in. GIDC, Dahej, Gujarat. Commenced operations from Sept. 2024. Launched a 2000 MT per annum.
Challenges persisted around fragmented clusters,. regulatory delays, and low R&D intensity, but import substitution and capacity expansion provided. resilience. Sustainability and innovation gained traction, with investments in bio-based feedstocks, waste-to- y delays, and low R&D intensity, but import substitution and capacity expansion provided. resilience.
Page 69 of 135. products stood at US$ 163.78 billion. Exports of petroleum products are 73.63 billion during April-December 2022. From April-March 2022, the export of agro-chemical was US$ 5.37 billion, dyes. were US$ 2.04 billion and the other dye intermediates were US$ 183.49 million. The import of agro-chemical was US$ 1.79 billion, dyes were US$ 0.31 billion and.
Since inception, it has. created over 520 pharmaceutical intermediates in 17 different. therapeutic areas, which are supplied to over 160 customers. The Company has a strong customer base with more than. 1 product with all the major customers. es in 17 different. therapeutic areas, which are supplied to over 160 customers. The Company has a strong customer base with more than.
Chemicals, and Petrochemicals Investment Region (PCPIR). policy and production-linked incentives (PLI) schemes have. bolstered manufacturers’ confidence in investing domestically. India, currently holding a modest 3.6% share in the global IR). policy and production-linked incentives (PLI) schemes have. bolstered manufacturers’ confidence in investing domestically.
That desire for sustainability. influences everything else within. our Company – the selection of. space or niche, the selection of. products, the cost at which we. commissioned manufacturing. facilities, the sizing of. manufacturing capacities, the. customer we would sell to (if at. all), the integrated nature of our. business model and the location. of our manufacturing units. d manufacturing.
R&D Centers. 5 (1)7 (5) 12 (6). 246. Capacity. ~1,400 kL~1,250 kL~2,650 kL. Source: Cohance LifeSciences Website published Investor Presentation. H1 FY25. Combined Business:. Key segment wise. strategy. Pg. R&D Centers. 5 (1)7 (5) 12 (6). 246. Capacity. ~1,400 kL~1,250 kL~2,650 kL. Source: Cohance LifeSciences Website published Investor Presentation. H1 FY25. Combined Business:. Key segment wise.
FY23-24 would see additional capacities. from Phase-II of Balabhadhrampuram. and new capacity expansion at Vilayat. This would lead us to reach a caustic d during. the year with capacity of ~22,000 TPA. FY23-24 would see additional capacities. from Phase-II of Balabhadhrampuram. and new capacity expansion at Vilayat. This would lead us to reach a caustic. capacity of 1,530 KTPA. Despite slowdown.
Consumption of speciality chemicals in India is low per. capita compared to the global averages. are expected to rise by around 10x, from about. USD 2 billion in 2021 to USD 21 billion. Consumption of speciality chemicals in India is low per. capita compared to the global averages. Given the potential. gap, Indian companies have the opportunity to expand their.
The team of Invati holds multiple. patents and is continuously engaged. in developing many more patentable. technologies for synthesising novel. molecules that can fulfill an array. of niche use cases. Directors. Himadri has two s multiple. patents and is continuously engaged. in developing many more patentable. technologies for synthesising novel. molecules that can fulfill an array.